Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Return on Capital Employed: 2015-2025

Historic Return on Capital Employed for vTv Therapeutics (VTVT) over the last 10 years, with Sep 2025 value amounting to -0.56%.

  • vTv Therapeutics' Return on Capital Employed rose 6.00% to -0.56% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.56%, marking a year-over-year increase of 6.00%. This contributed to the annual value of -1.24% for FY2024, which is 97.00% up from last year.
  • Per vTv Therapeutics' latest filing, its Return on Capital Employed stood at -0.56% for Q3 2025, which was up 47.24% from -1.07% recorded in Q2 2025.
  • In the past 5 years, vTv Therapeutics' Return on Capital Employed ranged from a high of -0.41% in Q3 2021 and a low of -10.84% during Q4 2023.
  • In the last 3 years, vTv Therapeutics' Return on Capital Employed had a median value of -1.00% in 2024 and averaged -2.01%.
  • Data for vTv Therapeutics' Return on Capital Employed shows a peak YoY increase of 3,668bps (in 2021) and a maximum YoY decrease of 1,012bps (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows vTv Therapeutics' Return on Capital Employed stood at -1.09% in 2021, then grew by 24bps to -0.85% in 2022, then crashed by 1,000bps to -10.84% in 2023, then soared by 1,016bps to -0.68% in 2024, then climbed by 6bps to -0.56% in 2025.
  • Its last three reported values are -0.56% in Q3 2025, -1.07% for Q2 2025, and -0.81% during Q1 2025.